Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

Erik D. Fagerholm, Robert Leech, Steven Williams +3

The glutamatergic modulator ketamine has been shown to rapidly reduce depressive symptoms in patients with treatment-resistant major depressive disorder (TRD). Although its mechani…